We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Saving Lives With Home Oxygen Therapy

By HospiMedica staff writers
Posted on 04 Jan 2007
A wider use of home oxygen therapy could save the lives of thousands of patients with chronic obstructive pulmonary disease (COPD), according to a new study.

Researchers from the RAND Corporation (Santa Monica, CA, USA) analyzed two years of medical records for 429 patients with obstructive lung disease living in 12 communities across the United States. More...
The study found different patterns of care provided to patients with asthma and COPD. Patients with asthma received about 67% of the care recommended for routine management of their illness, but only 48% of the care recommended when their condition worsened. The opposite pattern was seen among patients with COPD; patients received just 46% of the routine care recommended for COPD, compared with about 60% of recommended care when their symptoms were worse. Overall, researchers found that patients received 55% of the recommended care.

The researchers also found lower-than-expected use of tests that evaluate lung function among patients with COPD, and a low rate of the use of spacers with metered-dose inhalers for both COPD and asthma patients. The study was published in the November 2006 edition of the journal Chest.

"Our findings show that the quality of care provided to patients with obstructive lung disease is lacking, just as it is for many other common health problems,” said lead author Dr. Richard A. Mularski, a physician-researcher with the Center for Health Research, Kaiser Permanente (Oakland, CA, USA). "We found several specific areas of care that could be targeted for improvement efforts.”

The researchers estimate that increasing the number of COPD patients who receive oxygen treatment at home could prevent 27,000 to 57,000 deaths annually in the United States alone, while increasing the number of hospitalized asthmatic patients who receive systematic steroids could prevent nearly 2,000 additional deaths each year.

The RAND Corporation derives its name from a contraction of the term "research and development.”



Related Links:
RAND Corporation

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.